These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1379 related items for PubMed ID: 33915968

  • 1. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA, Ojo AB, Okolie C, Nwakama MC, Iyobhebhe M, Evbuomwan IO, Nwonuma CO, Maimako RF, Adegboyega AE, Taiwo OA, Alsharif KF, Batiha GE.
    Molecules; 2021 Apr 01; 26(7):. PubMed ID: 33915968
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X, Fu H, Yang S, Wang L, Liu AL, Wu S, Du GH.
    Molecules; 2017 Jul 26; 22(8):. PubMed ID: 28933746
    [Abstract] [Full Text] [Related]

  • 3. Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer's Treatment: A Computational Strategy.
    Jabir NR, Rehman MT, Tabrez S, Alserihi RF, AlAjmi MF, Khan MS, Husain FM, Ahmed BA.
    Curr Pharm Des; 2021 Jul 26; 27(20):2425-2434. PubMed ID: 33634754
    [Abstract] [Full Text] [Related]

  • 4. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M, Park C, Rampogu S, Zeb A, Lee KW.
    Int J Mol Sci; 2019 Feb 25; 20(4):. PubMed ID: 30823604
    [Abstract] [Full Text] [Related]

  • 5. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S, Singh BK.
    Curr Comput Aided Drug Des; 2020 Feb 25; 16(1):54-72. PubMed ID: 30827255
    [Abstract] [Full Text] [Related]

  • 6. In silico approaches to evaluate the molecular properties of organophosphate compounds to inhibit acetylcholinesterase activity in housefly.
    Marimuthu P, Lee YJ, Kim B, Seo SS.
    J Biomol Struct Dyn; 2019 Feb 25; 37(2):307-320. PubMed ID: 29322868
    [Abstract] [Full Text] [Related]

  • 7. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H, Jiang Y, Zhan J, Sun Y.
    Bioorg Chem; 2021 Sep 25; 114():105149. PubMed ID: 34252860
    [Abstract] [Full Text] [Related]

  • 8. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P, Bhat J, Puzyn T, Roy K.
    J Biomol Struct Dyn; 2019 Mar 25; 37(5):1282-1306. PubMed ID: 29578387
    [Abstract] [Full Text] [Related]

  • 9. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB, Aguan K, Mitra S, Bhattacharjee A.
    J Biomol Struct Dyn; 2017 Jun 25; 35(8):1729-1742. PubMed ID: 27410776
    [Abstract] [Full Text] [Related]

  • 10. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A, Hu J, Wang L, Zhong G, Pan J, Wu Z, Hui A.
    J Mol Model; 2015 Oct 25; 21(10):277. PubMed ID: 26438408
    [Abstract] [Full Text] [Related]

  • 11. In silico exploration of promising heterocyclic molecules against both acetylcholinesterase and butyrylcholinesterase enzymes.
    Nguyen HD, Kim MS.
    J Biomol Struct Dyn; 2024 Sep 25; 42(14):7128-7149. PubMed ID: 37477246
    [Abstract] [Full Text] [Related]

  • 12. Lead Identification Through In Silico Studies: Targeting Acetylcholinesterase Enzyme Against Alzheimer's Disease.
    Agarwal D, Kumar S, Ambatwar R, Bhanwala N, Chandrakar L, Khatik GL.
    Cent Nerv Syst Agents Med Chem; 2024 Sep 25; 24(2):219-242. PubMed ID: 38288823
    [Abstract] [Full Text] [Related]

  • 13. Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay.
    Jang C, Yadav DK, Subedi L, Venkatesan R, Venkanna A, Afzal S, Lee E, Yoo J, Ji E, Kim SY, Kim MH.
    Sci Rep; 2018 Oct 08; 8(1):14921. PubMed ID: 30297729
    [Abstract] [Full Text] [Related]

  • 14. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
    Ali B, Jamal QM, Shams S, Al-Wabel NA, Siddiqui MU, Alzohairy MA, Al Karaawi MA, Kesari KK, Mushtaq G, Kamal MA.
    CNS Neurol Disord Drug Targets; 2016 Oct 08; 15(5):624-8. PubMed ID: 26996169
    [Abstract] [Full Text] [Related]

  • 15. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S, Loganathan C, Sakayanathan P, Karthikeyan S, Stephen AD, Marimuthu DK, Ravichandran S, Sivalingam V, Thayumanavan P.
    Int J Biol Macromol; 2021 Aug 31; 185():750-760. PubMed ID: 34216669
    [Abstract] [Full Text] [Related]

  • 16. Identification of Potent and Selective Acetylcholinesterase/Butyrylcholinesterase Inhibitors by Virtual Screening.
    Xu T, Li S, Li AJ, Zhao J, Sakamuru S, Huang W, Xia M, Huang R.
    J Chem Inf Model; 2023 Apr 24; 63(8):2321-2330. PubMed ID: 37011147
    [Abstract] [Full Text] [Related]

  • 17. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I, Melkemi N, Salah T, Ghalem S.
    Comput Biol Chem; 2018 Jun 24; 74():304-326. PubMed ID: 29747032
    [Abstract] [Full Text] [Related]

  • 18. Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.
    Deb PK, Sharma A, Piplani P, Akkinepally RR.
    Mol Divers; 2012 Nov 24; 16(4):803-23. PubMed ID: 22996404
    [Abstract] [Full Text] [Related]

  • 19. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P, Kar S, Roy K.
    Biosystems; 2014 Feb 24; 116():10-20. PubMed ID: 24325852
    [Abstract] [Full Text] [Related]

  • 20. Pharmacophore-based virtual screening and molecular docking to identify promising dual inhibitors of human acetylcholinesterase and butyrylcholinesterase.
    Mascarenhas AMS, de Almeida RBM, de Araujo Neto MF, Mendes GO, da Cruz JN, Dos Santos CBR, Botura MB, Leite FHA.
    J Biomol Struct Dyn; 2021 Oct 24; 39(16):6021-6030. PubMed ID: 32705955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.